Abstract
There has been tremendous progress in the identification, prevention, control and study of prion diseases. This update presents a brief Summary of the history of Prion theory and the national participation in relation to human and animal health, which may partly explain why we have presence in our country of Creutzfeldt-Jakob disease (CJD) only in its sporadic variant and an absence of bovine spongiform encephalopathy (BSE or “mad cow disease”) until today. These also rule out the possible occurrence of variant CJD (vCJ), which is a zoonotic disease. Finally, as recent advances in basic research, we show a similarity in prion amyloid aggregate structure formed by prions, ßA amyloid aggregates of Alzheimer's disease and alpha synuclein of Parkinson disease, which until recently began being investigated. A mechanism of neural toxicity, nucleation, transmission misfolding and restriction of transmission between species is discussed.
References
AGUZZI A, HAASS C. Games played by rogue proteins in prion disorders and Alzheimer's disease. Science. 2003;302:814-8.
BRUNDIN P, MELKI R, KOPITO, R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat. Rev. Mol. Cell Biol. 2010; 11, 301-307.
OLANOW CW, BRUNDIN P. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder? Mov Disord 2013; 28: 31-40.
TORO G, DÍAZ A, SAAD C. Ayer, hoy y mañana? de la teoría Prión. Acta Neurol Colomb. 2002;184:187-203.
KIRSBAUM WR. Creutzfeldt-Jakob Disease. New York-American Elsevier, 1968.
GAJDUSEK DC, GIBBS CJ JR, ALPERS M. Transmission and passage of experimenal "kuru" to chimpanzees. Science. 1967;155:212-4.
GAJDUSEK DC, GIBBS CJ JR, ALPERS M. Transmission and passage of experimenal "kuru" to chimpanzees. Science. 1967;155:212-4.
MATHEWS JD, GLASSE R, LINDENBAUM S. Kuru and cannibalism. Lancet. 1968;2:449-52.
DUFFY P, WOLF J, COLLINS G, DEVOE AG, STREETEN B, COWEN D. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med. 1974;290:692
GRIFFITH JS. Self-replication and scrapie. Nature. 1967;215:1043-4.
LATARJET R, MUEL B, HAIG DA, CLARKE MC, ALPER T. Inactivation of the scrapie agent by near monochromatic ultraviolet light. Nature. 1970;227:1341-3.
PRUSINER SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136-44.
CHIESA R, HARRIS DA. Prion diseases: what is the neurotoxic molecule? Neurobiol Dis. 2001;8:743-63.
FRADKIN JE, SCHONBERGER LB, MILLS JL, GUNN WJ, PIPER JM, WYSOWSKI DK, ET AL. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA. 1991;265:880-4.
TORO G, PACHECO OE, SIERRA UE, BELTRAN M, DÍAZ A, PARRA EA, BONILLA E. Encefalopatías subagudas Espongiformes Transmisibles (ESET). La teoría prión-Enfermedades priónicas Acta Neurol Colomb. 2005;21:134-62.
BARON TG, BIACABE AG, BENCSIK A AND LANGEVELD JPM. Transmission of new bovine prion to mice. Emerg Infect Dis. 2006;12:1125-1128.
COMOY EE, CASALONEC, LESCOUTRA-ETCHEGARAY N, ZANUSSO G, FREIRE S, MARCÉ D, ET AL. 2008 Atypical BSE (BASE) Transmitted from Asymptomatic Aging Cattle to a Primate. PLoS ONE 3 (8): e3017. Doi:10.1371/journal.pone.0003017.
KONG Q, ZHENG M, CASALONE C, QUING L, HUANG S, CHAKRABORTY B, ET AL. Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. J Virol. 2008;82:3697-701.
BERINGUE V, BENCSIK A, LE DUR A, REINE F, LAI TL, CHENAIS N, ET AL. TAFS Position Paper on Atypical scrapie and Atypical BSE. (May 16, 2007), Isolation from cattle of a Prion Strain distinct that causing Bovine Spongiform Encephalopathy. PLoS Pathogens. 2006;2:E112. 0956-0963.
CASALONE G, ZANUSSO P, ACUTIS S, FERRARI L, CAPUCCI F, TAGLIAVINI S, ET AL. Identification of a second bovine amyloidotic spongiform encephalopathy: Molecular similarities with sporadic Creutzfeldt-Jakob disease C. Proc Nat Acad Sci. 2004; 101:3065-70.
BUSCHMANN A, GRETZSCHEL A, BIACABE AG, SCHIEBEL K, CORONA C, HOFFMANN C, ET AL. Atypical BSE in Germany proof of transmissibility and biochemical characterization. Vet Microbiol. 2006;117:103-16.
ORGANIZACIÓN MUNDIAL DE SANIDAD ANIMAL OIE. Manual de las pruebas de Diagnóstico y de las Vacunas para los animales Terrestres. 2013; Capítulo 2.4.6 Encefalopatía espongiforme bovina (NB: Versión adoptada en mayo de 2010).
CAPOBIANCO R, CASALONE C, SUARDI S, MANGIERI M, MICCOLO C, LUMIDO L, ET AL. Conversion of the BASE Prion Strain into the BSE strain: The Origin of BSE. PLoS Pathogens. 2007;3:e31. 1-8.
AGUILAR-CALVO P, GARCÍA C, ESPINOSA JC. Prion and prion-like diseases in animals. Virus Res. (2014), http://dx.doi.org/10.1016/j.virusres.2014.11.026
LUNDMARK K,WESTERMARK GT, NYSTROM S, MURPHY CL, SOLOMON A, WESTERMARK P. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc. Natl. Acad. Sci. USA. 202; 99:6979-84
KRAUS A, GROVEMAN BR, CAUGHEY B. Prions and the Potential Transmissibility of Protein Misfolding Diseases. Annu. Rev. Microbiol. 2013. 67:543-64
BRAAK H, BRAAK E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol. 1991;1:213-6.
HARDY J, SELKOE DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353-6.
STÖHR J, WATTS JC, MENSINGER ZL, OEHLER A, GRILLO SK, DEARMOND SJ, ET AL. Purified and synthetic Alzheimer's amyloid beta (A?) prions. Proc Natl Acad Sci U S A. 2012;109:11025-30.
EISELE YS, OBERMÜLLER U, HEILBRONNER G, BAUMANN F, KAESER SA, WOLBURG H, et al. Peripherally applied A beta-containing inoculates induce cerebral beta-amyloidosis. Science. 2010;330:980-82.
SCHENK D, BARBOUR R, DUNN W, GORDON G, GRAJEDA H, GUIDO T, ET AL. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature.1999; 400:173-7.
JANUS C, PEARSON J, MCLAURIN J, MATHEWS PM, JIANG Y, SCHMIDT SD, ET AL. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 2000; 408:979-82.
ORGOGOZO JM, GILMAN S, DARTIGUES JF, LAURENT B, PUEL M, KIRBY LC, ET AL. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology. 2003;61:46-54.
GILMAN S, KOLLER M, BLACK RS, JENKINS L, GRIFFITH SG, FOX NC, ET AL. Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology. 2005;64:1553-62.
ANGOT E, STEINER JA, HANSEN C, LI JY, BRUNDIN P. Are synucleinopathies prion-like disorders? Lancet Neurol. 2010;9:1128-38.
DUNNING CJ, GEORGE S., AND BRUNDIN, P. (2013) What's to like about the prion-like hypothesis for the spreading of aggregated ?-synuclein in Parkinson disease? Prion 2013;7:92-7.
COLLINGE J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci. 2001;24:519-50.
TORO G, ROMÁN G, URIBE C. Neurociencia. Contribución a la historia. Enfermedades "viejas" y "nuevas". Editor Mauricio Pérez. Instituto Nacional de Salud. Bogotá. Colombia. Primera edición. 2006: 1-113.
SHEWMAKER F, WICKNER RB, TYCKO R. Amyloid of the prion domain of Sup35p has an in-register parallel -sheet structure. Proc Natl Acad Sci USA.2006;103:19754-9.
BAXA U, WICKNER RB, STEVEN AC, ANDERSON D, MAREKOV L, YAU W-M, ET AL. Characterization of sheet structure in Ure2p1-89 yeast prion fibrils by solid state nuclear magnetic resonance. Biochemistry. 2007;46:13149-62.
CHIEN P, WEISSMAN JS, DEPACE AH. Emerging principles of conformation-based prion inheritance. Annu Rev Biochem. 2004;73:617-56.
RITTER C, MADDELEIN ML, SIEMER AB, LUHRS T, ERNST M, MEIER BH, ET AL. Correlation of structural elements and infectivity of the HET-s prion. Nature. 2005; 435:844-8.
WASMER C, LANGE A, VAN MELCKEBEKE H, SIEMER AB, RIEK R, MEIER BH. Amyloid fibrils of the HET-s(218-279) prion form a beta solenoid with a triangular hydrophobic core. Science. 2008;319:1523-6.
ANTZUTKIN ON, BALBACH JJ, LEAPMAN RD, RIZZO NW, REED J, TYCKO R. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci USA. 2000;97:13045-50.
TYCKO R. Molecular structure of amyloid fibrils: insights from solid-state NMR. Quart Revs Biophys. 2006;1:1-55
PETKOVA AT, YAU WM, TYCKO R. Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry. 2006;45:498-512.
ANTZUTKIN ON, BALBACH JJ, TYCKO R. Site-specific identification of non-beta-strand conformations in Alzheimer's beta-amyloid fibrils by solid-state NMR. Biophys J. 2003;84:3326-35.
PARAVASTU AK, LEAPMAN RD, YAU WM, TYCKO R. Molecular structural basis for polymorphism in Alzheimer's -amyloid fibrils. Proc Natl Acad Sci USA. 2008; 105:18349-54.
ROSS ED, MINTON AP, WICKNER RB. Prion domains: sequences, structures and interactions. Nat Cell Biol. 2005;7:1039-44.
NICOLL AJ, PANICO S, FREIR DB, WRIGHT D, TERRY C, RISSE E, ET AL. Amyloid-ß nanotubes are associated with prion protein-dependent synaptotoxicity. Nat Commun. 2013;4:2416.
DERDOWSKI A, SINDI SS, KLAIPS CL, DISALVO S, SERIO TR. A size threshold limits prion transmission and establishes phenotypic diversity. Science. 2010;330:680-3.
PARK L, ZHOU J, ZHOU P, PISTICK R, EL JAMAL S, YOUNKIN L, ET AL. Innate Immunity receptor CD36 promotes cerebral amyloid angiopathy. Proc Natl Acad Sci U S A. 2013;110:3089-94. doi: 10.1073/pnas.1300021110.
PEGGION C, SORGATO MC, BERTOLI A. Prions and Prion-Like Pathogens in Neurodegenerative Disorders. Pathogens 2014;3:149-163; doi:10.3390/pathogens3010149.
COHEN SIA, AROSIO P, PRESTO J, KURUDENKANDY FR, BIVERSTAL H, DOLFE L, ET AL. A molecular chaperone braks the catalytic cycle that generate toxic AB oligomers. Nat Struct Mol Biol. 2015; Advanced publication doi:10.1038/nsmb.2971
ZHO M, OTTENBERG G, SFERRAZZA GF, HUBB C, FALLAHI M, RUMBAUGH G, ET AL. Neuronal death induced by misfolded prion protein is due to NAD+ deletion and can be relieved in vitro and in vivo by NAD+ replenishment. 2015; Advanced publication doi:10.1093/brain/awv002.
GJONESKA E, PFENNING AR, MATHYS H, QUON G, KUNDAJE A, TSAI LH, ET AL. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease. Nature. 2015; 518:365-72. doi:10.1038/nature14252.
GENEREUX JC, QU S, ZHOU MH, RYNO LM, WANG SY, SHOULDERS MD, ET AL. Embo J. 2015;31:4-19.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.